The antimicrobial susceptibility in adult invasive pneumococcal disease in the era of pneumococcus vaccination: A hospital-based observational study in Taiwan.
CONCLUSION: The increase in the prevalence of CNSP using meningitis breakpoint was observed. For treating pneumococcal meningitis, empirical monotherapy with ceftriaxone might not be adequate. Imipenem and meropenem might not be a good choice for empirical treatment of adult IPDs. Antibiotic resistance of pneumococcus to ceftriaxone, cefepime, imipenem and meropenem were associated with 13-velent pneumococcal conjugate vaccine serotypes.
PMID: 32063458 [PubMed - as supplied by publisher]
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Lee MC, Kuo KC, Lee CH, Hsieh YC, Tsai MH, Huang CT, Huang YC Tags: J Microbiol Immunol Infect Source Type: research
More News: Allergy & Immunology | Ceftriaxone | Epidemiology | Men | Meningitis | Meningitis Vaccine | Microbiology | Pneomococcal Vaccine | Rocephin | Study | Taiwan Health | Vaccines